NBCI Declares a National Health Emergency in the Black Church
NBCI Clinical Approach to HED
The National Black Church Initiative (NBCI) will conduct itself with the highest ethical standards in advocating clinical trials participation by our faith based communities. The mission of NBCI clinical program is to increase the representation of African Americans in clinical trials. It is imperative that African Americans participate in clinical trials to assure that our population receives the benefits of cutting edge drug therapy and modern medical practice.
This is a major pillar in our efforts to deal with issues of health disparities.
NBCI seeks to assure our faith base communities of the value, benefits, protections
and trustworthiness of the clinical trials for which it advocates and encourages
participation. In doing so, NBCI itself must be assured of the protections and
the appropriateness of the protocols and the processes. Therefore, we have adopted
a set of core principles that will govern our decisions regarding involvement
in any clinical trial:
Principle 1
There must be complete education of the potential clinical trial participants regarding the requirements of the trial as well as the risks and the benefits to patients with respect to their participation. In addition to assuring that protocols are consistent with religious values and ethical standards, NBCI will guarantee that the clinical trial meets with all regulatory requirements including but not limited to:
- Ongoing inform consent process including signature of properly constructed document by all trial participants or their legally authorized representative;
- Proper review and approval by a duly constituted and certified Institutional Review Board;
- Accessibility of resource for answering all participants’ questions in a culturally and linguistically appropriate manner;
- An appropriate period for patient deliberation on the decision to participate;
- Culturally and linguistically appropriate literature, video, and web based education modules concerning the trial when these tools are used.
Principle 2
Participants must be assured of an easy process for reporting serious life threatening or non-life threatening side effects and acceptable emergency procedures for receiving care in a timely manner.
Principle 3
NBCI will advocate for participation of patients in clinical trials with clinical investigators that have been trained in Good Clinical Practice regulations, ethics, and cultural competence.
Principle 4
There must be adequate indemnification by sponsor, legal safeguards for program participants and host agencies addressing issues of liability for the test product and the trial.
Principle 5
NBCI requires that there be adequate resources to launch and sustain a church/community based awareness program regarding all aspects of the trial.
Principle 6
All agreements must be in writing with proper legal review by involved parties. There must be sufficient budgetary commitment to the trial facilitators as well as partners and participants depending on the nature of the trial.
Principle 7
NBCI must be assured of adequate resources for completion of the clinical trial and achieving and reporting the knowledge of benefits and risks for diverse populations participating in the trial.
Parents and others can find federally funded research
programs by
consulting this NIH Web site.